A
Figure 1.
Susceptibility weighted imaging with 3D SWAN in high resolution, 0.3 x 0.4 x 1.2/-0.6 mm. (A) Magnitude image in MinIP; (B) filtered phase image in MinIP; (C) post-processed fusion of magnitude and filtered phase images (using ADD/SUB tool) in MinIP. Images courtesy of RIKEN Center for Brain Science, Wako, Saitama, Japan.
B
Figure 1.
Susceptibility weighted imaging with 3D SWAN in high resolution, 0.3 x 0.4 x 1.2/-0.6 mm. (A) Magnitude image in MinIP; (B) filtered phase image in MinIP; (C) post-processed fusion of magnitude and filtered phase images (using ADD/SUB tool) in MinIP. Images courtesy of RIKEN Center for Brain Science, Wako, Saitama, Japan.
C
Figure 1.
Susceptibility weighted imaging with 3D SWAN in high resolution, 0.3 x 0.4 x 1.2/-0.6 mm. (A) Magnitude image in MinIP; (B) filtered phase image in MinIP; (C) post-processed fusion of magnitude and filtered phase images (using ADD/SUB tool) in MinIP. Images courtesy of RIKEN Center for Brain Science, Wako, Saitama, Japan.
A
Figure 2.
Non-contrast enhanced MR angiography of the brain with 3D TOF in high resolution, 0.4 x 0.5 x 0.6 mm. (A) 3D TOF in 3D MIP; (B) 3D TOF post-processed with volume illumination. Images courtesy of University of Iowa, Iowa City, IA, US.
B
Figure 2.
Non-contrast enhanced MR angiography of the brain with 3D TOF in high resolution, 0.4 x 0.5 x 0.6 mm. (A) 3D TOF in 3D MIP; (B) 3D TOF post-processed with volume illumination. Images courtesy of University of Iowa, Iowa City, IA, US.
A
Figure 3.
2D proton density FatSat imaging of the knee in high resolution. (A) Sagittal PD FatSat: 0.4 x 0.4 x 2.5 mm, 2:06 min. and (B) zoomed image of tibiofemoral cartilage. Images courtesy of Fondazione Imago7, University of Pisa, Pisa, Italy.
B
Figure 3.
2D proton density FatSat imaging of the knee in high resolution. (A) Sagittal PD FatSat: 0.4 x 0.4 x 2.5 mm, 2:06 min. and (B) zoomed image of tibiofemoral cartilage. Images courtesy of Fondazione Imago7, University of Pisa, Pisa, Italy.
next arrow_PURPLE.svgprevious arrow_PURPLE.svg
Subscribe Now
Manage Subscription
FOLLOW US
Contact Us Cookie PreferencesPrivacy PolicyCalifornia Privacy Policy
Do Not Sell or Share My Personal InformationTerms & ConditionsSecurity
© 2024 GE HealthCare. GE is a trademark of General Electric Company. Used under trademark license.
IN PRACTICE

7.0T image gallery

IP_7T image gallery Figure 1A.jpg
A
IP_7T image gallery Figure 1B.jpg
B
IP_7T image gallery Figure 1C.jpg
C
Figure 1. Susceptibility weighted imaging with 3D SWAN in high resolution, 0.3 x 0.4 x 1.2/-0.6 mm. (A) Magnitude image in MinIP; (B) filtered phase image in MinIP; (C) post-processed fusion of magnitude and filtered phase images (using ADD/SUB tool) in MinIP. Images courtesy of RIKEN Center for Brain Science, Wako, Saitama, Japan.
IP_7T image gallery Figure 2A.jpg
A
IP_7T image gallery Figure 2B.jpg
B
Figure 2. Non-contrast enhanced MR angiography of the brain with 3D TOF in high resolution, 0.4 x 0.5 x 0.6 mm. (A) 3D TOF in 3D MIP; (B) 3D TOF post-processed with volume illumination. Images courtesy of University of Iowa, Iowa City, IA, US.
IP_7T image gallery Figure 3A.jpg
A
IP_7T image gallery Figure 3B.jpg
B
Figure 3. 2D proton density FatSat imaging of the knee in high resolution. (A) Sagittal PD FatSat: 0.4 x 0.4 x 2.5 mm, 2:06 min. and (B) zoomed image of tibiofemoral cartilage. Images courtesy of Fondazione Imago7, University of Pisa, Pisa, Italy.
END_MARK_In_Practice-01.png